{"schema_version":"secwatch.filing_event.v1","accession":"0001023024-24-000050","form_type":"8-K","ticker":"ANIP","cik":"0001023024","company_name":"ANI PHARMACEUTICALS INC","filed_at":"2024-04-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.924581+00:00","generated_at":"2026-06-03T21:27:39.406161+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"low","headline":"ANI Pharmaceuticals provides investor presentation at Piper Sandler symposium; details unavailable","bullets":["Filing announces CEO Nikhil Lalwani and CFO Stephen Carey meeting investors at Piper Sandler Spring Biopharma Symposium on April 17, 2024.","Exhibit 99.1 investor presentation furnished but not included in provided text; no financial data or guidance disclosed in filing body.","Presentation not filed under Securities Act; standard Form 8-K items 2.02 and 7.01 invoked."],"urls":{"canonical":"https://secwatch.observer/filing/0001023024-24-000050","json":"https://secwatch.observer/filing/0001023024-24-000050.json","markdown":"https://secwatch.observer/filing/0001023024-24-000050.md","text":"https://secwatch.observer/filing/0001023024-24-000050.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1023024/000102302424000050/0001023024-24-000050-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1023024/000102302424000050/ani-20240417.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T21:27:39.406161+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}